临床试验

Stratagen Quantitative Prostate MRI Platform Pilot Study

NCT：NCT06985238 · ACTIVE_NOT_RECRUITING

NCT编号NCT06985238

状态ACTIVE_NOT_RECRUITING

开始日期2025-09-24

完成时间2027-05-30

SponsorStratagen Bio, Inc. (INDUSTRY)

First posted2025-05-22

Last updated2026-10-09

简要摘要

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。